Blood Coagulation Analyzers Market Size, Share, Opportunities, And Trends By Product (Analyzers, Consumables), By Test Type (Fibrinogen Testing, D-Dimer Testing, Platelet Function Tests, Other Coagulation Tests), By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, Others), By End-User (Hospitals, Diagnostic Centres, Others), And By Geography - Forecasts From 2024 To 2029

The blood coagulation analyzers market is anticipated to grow significantly over the forecast period.

Blood coagulation analyzers are essential medical devices used in clinical laboratories to assess the coagulation status of patients. These analyzers play a crucial role in diagnosing and monitoring various conditions related to blood clotting disorders, such as thrombosis, hemophilia, and von Willebrand disease.

By measuring parameters like prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR), blood coagulation analyzers help healthcare professionals evaluate the clotting function of a patient's blood. They provide accurate and timely results, enabling healthcare providers to make informed decisions regarding treatment plans and interventions. With advancements in technology, modern blood coagulation analyzers offer improved efficiency, precision, and automation, enhancing the quality of patient care in clinical settings.

Market Drivers

• Increase in heart-related ailments linked to obesity.

The rising prevalence of cardiovascular diseases and blood disorders among the population is anticipated to serve as the primary driver for the growth of the blood coagulation analyzers market. Treating severe blood-related conditions can incur substantial healthcare expenses, especially with the progressive increase in costs. Additionally, the growing elderly population is expected to make a significant contribution to the blood coagulation analyzers market expansion. According to data from the American Cancer Society (CLL), around 21,250 new cases of chronic lymphocytic leukemia were reported in the United States in 2021.

• Enhanced Precision of Analytical Instruments

Advancements in blood coagulation testing technology have simplified and enhanced the accuracy of the process. With increasing obesity rates, there is a growing need for comprehensive blood coagulation testing to monitor blood sugar levels. Consequently, the demand for blood coagulation analyzers is expected to experience significant growth due to these factors.

North America is anticipated to hold a significant market share

The North American region is poised to capture a substantial market share, driven by several key factors. These include the rising prevalence of chronic blood disorders, the growing adoption of laboratory automation, and the implementation of strategic initiatives by industry players. For example, according to a February 2020 report by the Centers for Disease Control and Prevention (CDC), the exact number of individuals in the United States affected by deep vein thrombosis is uncertain, but estimates suggest it could be as high as 900,000 (equivalent to 1 to 2 per 1,000 people). Moreover, the CDC estimates that between 60,000 to 100,000 Americans die from venous thromboembolism annually.

Given these statistics, there is an increasing need for early detection of blood abnormalities, driving the demand for coagulation analyzers in the region and facilitating market growth. Furthermore, various industry participants are implementing strategic initiatives to expand their market presence. For instance, in April 2020, the American company Haemonetics Corporation acquired Enicor, a developer of blood coagulation diagnostic systems.

Similarly, the American Clinical Laboratory Association (ACLA) launched the Stop Lab Cuts campaign in July 2022 to improve clinical laboratory infrastructure and enhance patient care delivery. These efforts are expected to accelerate market expansion by addressing infrastructure needs and increasing funding in the country. As a result, the market is anticipated to experience significant growth in the forecast period.

Market Developments

• In July 2022, HORIBA Medical introduced the newest versions of the Yumizen G800 and G1550 hemostasis analyzers, accompanied by a variety of pre-prepared reagents specifically tailored for standard blood coagulation assessments. This extension of their product range signifies that HORIBA Medical now offers a complete array of hemostasis systems and innovative reagents, meeting the requirements of laboratories across various sizes and requirements.
• In October 2021, Trivitron Healthcare, a prominent medical devices company, unveiled a new range of Coagulation Analyzer products developed by Diagon Ltd. In collaboration with Diagon-Vanguard Diagnostics India, Trivitron introduced these products to the Indian Diagnostics Market following a partnership agreement between the two companies. This launch is expected to benefit the medical community by improving the accuracy of clinical decision-making and expanding patient management capabilities. The newly introduced products comprise the COAG Line, which includes automated, semi-automated, and Point-of-Care (POC) systems manufactured by Diagon Hungary. These systems aim to reduce bleeding risks in complex surgeries, assess the effectiveness of hemostatic therapies, and evaluate the impact of anticoagulant medications.
• In February 2021, Siemens Healthineers and Sysmex Corporation announced the extension of their longstanding global agreement for the supply, distribution, sales, and service of a wide range of hemostasis products, with a multi-year renewal.

Market Segmentation

• By Product
  • Analyzers
  • Consumables
• By Test Type
  • Fibrinogen Testing
  • D-Dimer Testing
  • Platelet Function Tests
  • Other Coagulation Tests
• By Technology
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Others
• By End-User
  • Hospitals
  • Diagnostic Centres
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. BLOOD COAGULATION ANALYZER MARKET BY PRODUCT

5.1. Introduction

5.2. Analyzers

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Clinical Laboratory Analyzers

5.2.4. Point of Care Analyzers

5.3. Consumables

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

6. BLOOD COAGULATION ANALYZER MARKET BY TEST TYPE

6.1. Introduction

6.2. Fibrinogen Testing

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. D-Dimer Testing

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Platelet Function Tests

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.5. Other Coagulation Tests 

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

7. BLOOD COAGULATION ANALYZER MARKET BY TECHNOLOGY  

7.1. Introduction

7.2. Optical Technology

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Mechanical Technology

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.4. Electrochemical Technology

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

7.5. Others 

7.5.1. Market Trends and Opportunities

7.5.2. Growth Prospects

8. BLOOD COAGULATION ANALYZER MARKET BY END-USER  

8.1. Introduction

8.2. Hospitals

8.2.1. Market Trends and Opportunities

8.2.2. Growth Prospects

8.3. Diagnostic Centers

8.3.1. Market Trends and Opportunities

8.3.2. Growth Prospects

8.4. Others 

8.4.1. Market Trends and Opportunities

8.4.2. Growth Prospects

9. BLOOD COAGULATION ANALYZER MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Product

9.2.2. By Test Type

9.2.3. By Technology 

9.2.4. By End User

9.2.5. By Country

9.2.5.1. United States

9.2.5.1.1. Market Trends and Opportunities

9.2.5.1.2. Growth Prospects

9.2.5.2. Canada

9.2.5.2.1. Market Trends and Opportunities

9.2.5.2.2. Growth Prospects

9.2.5.3. Mexico

9.2.5.3.1. Market Trends and Opportunities

9.2.5.3.2. Growth Prospects

9.3. South America

9.3.1. By Product

9.3.2. By Test Type

9.3.3. By Technology 

9.3.4. By End User

9.3.5. By Country 

9.3.5.1. Brazil

9.3.5.1.1. Market Trends and Opportunities

9.3.5.1.2. Growth Prospects

9.3.5.2. Argentina

9.3.5.2.1. Market Trends and Opportunities

9.3.5.2.2. Growth Prospects

9.3.5.3. Others

9.3.5.3.1. Market Trends and Opportunities

9.3.5.3.2. Growth Prospects

9.4. Europe

9.4.1. By Product

9.4.2. By Test Type

9.4.3. By Technology 

9.4.4. By End User

9.4.5. By Country

9.4.5.1. United Kingdom

9.4.5.1.1. Market Trends and Opportunities

9.4.5.1.2. Growth Prospects

9.4.5.2. Germany

9.4.5.2.1. Market Trends and Opportunities

9.4.5.2.2. Growth Prospects

9.4.5.3. France

9.4.5.3.1. Market Trends and Opportunities

9.4.5.3.2. Growth Prospects

9.4.5.4. Italy

9.4.5.4.1. Market Trends and Opportunities

9.4.5.4.2. Growth Prospects

9.4.5.5. Spain

9.4.5.5.1. Market Trends and Opportunities

9.4.5.5.2. Growth Prospects

9.4.5.6. Others

9.4.5.6.1. Market Trends and Opportunities

9.4.5.6.2. Growth Prospects

9.5. Middle East and Africa

9.5.1. By Product

9.5.2. By Test Type

9.5.3. By Technology 

9.5.4. By End User

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.1.1. Market Trends and Opportunities

9.5.5.1.2. Growth Prospects

9.5.5.2. UAE

9.5.5.2.1. Market Trends and Opportunities

9.5.5.2.2. Growth Prospects

9.5.5.3. Others

9.5.5.3.1. Market Trends and Opportunities

9.5.5.3.2. Growth Prospects

9.6. Asia Pacific

9.6.1. By Product

9.6.2. By Test Type

9.6.3. By Technology 

9.6.4. By End User

9.6.5. By Country

9.6.5.1. Japan

9.6.5.1.1. Market Trends and Opportunities

9.6.5.1.2. Growth Prospects

9.6.5.2. China

9.6.5.2.1. Market Trends and Opportunities

9.6.5.2.2. Growth Prospects

9.6.5.3. India

9.6.5.3.1. Market Trends and Opportunities

9.6.5.3.2. Growth Prospects

9.6.5.4. South Korea

9.6.5.4.1. Market Trends and Opportunities

9.6.5.4.2. Growth Prospects

9.6.5.5. Taiwan

9.6.5.5.1. Market Trends and Opportunities

9.6.5.5.2. Growth Prospects

9.6.5.6. Thailand

9.6.5.6.1. Market Trends and Opportunities

9.6.5.6.2. Growth Prospects

9.6.5.7. Indonesia

9.6.5.7.1. Market Trends and Opportunities

9.6.5.7.2. Growth Prospects

9.6.5.8. Others

9.6.5.8.1. Market Trends and Opportunities

9.6.5.8.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Abbott Laboratories

11.2. Beckman Coulter Inc.

11.3. Diagnostica Stago Sas

11.4. Eurolyser Diagnostica GmbH 

11.5. F. Hoffmann-La Roche Ltd

11.6. Siemens Healthineers AG

11.7. Helena Laboratories

11.8. Meril Life Sciences Pvt. Ltd.

Abbott Laboratories

Beckman Coulter Inc.

Diagnostica Stago Sas

Eurolyser Diagnostica GmbH 

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

Helena Laboratories

Meril Life Sciences Pvt. Ltd.